A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

169 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-28

Study Completion Date

2022-07-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if use of the SU-VEID™ in children facilitates an increase success rate of peripheral intravenous starts, in comparison to the conventional method of vein entry techniques.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Vein Imaging Device on First-Attempt Success in Peripheral Intravenous Catheter Insertion

NCT07006038

Catheterization, Peripheral Catheters, Indwelling Catheter Complications +2 more

COMPLETED NA

Ultrasound-guided Peripheral Intravenous Catheter Insertion Technique

NCT04218643

Catheterization, Peripheral Venous Phlebitis Infiltration

TERMINATED NA

A Comparison of the Success Rate Of Cannulation Between The Accuvein Apparatus And Standard Technique

NCT01042613

Cannulation

COMPLETED NA

The "Peripheral Access Utilizing Sonographic Evaluation" Study

NCT02360163

DIVA

WITHDRAWN NA

Superior Venous Access, Midline vs Ultrasound IVs

NCT03440944

Vascular Access Complication Ultrasound Therapy; Complications

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intravenous Access

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard IV Insertion

Pediatric patients in surgical pre-op requiring an IV catheter for surgery will have standard IV insertion

Group Type NO_INTERVENTION

No interventions assigned to this group

SU-VEID assisted IV Insertion

Pediatric patients in surgical pre-op requiring an IV catheter for surgery will have IV insertion using SU-VEID device

Group Type OTHER

Single Use Vein Entry Indicator Device

Intervention Type DEVICE

Electronic pressure sensing device, integrated to a conventional needle catheter, and which indicates continuously during intravenous cannulation whether the tip of the needle is inside or outside of a vein, to assist a clinician in intravenous cannulation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Single Use Vein Entry Indicator Device

Electronic pressure sensing device, integrated to a conventional needle catheter, and which indicates continuously during intravenous cannulation whether the tip of the needle is inside or outside of a vein, to assist a clinician in intravenous cannulation.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

SU-VEID

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient age \< 18 years old.
* Pediatric patients in surgical pre-op (0-18 years old), requiring an I.V. catheter for surgery who are difficult venous access.
* Written informed consent/ assent from the patient or legal guardian.